Clinical Trials at UC Davis Health System

Active Clinical Trials

All Trials Recruiting Trials    

Principal InvestigatorTitleDepartment
Gandara, DavidA Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)Cancer Center
Gandara, DavidMARVEL: Marker Validation of Erlotinib in Lung Cancer, A Phase III Biomarker Validation Study of Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Randomized to Pemetrexed Versus ErlotinibCancer Center
Valicenti, RichardA Phase II Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical ProstatectomyCancer Center
Ducore, JonathanIntensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine StrategiesCancer Center
Welborn, JeannaPhase IIB, Multicenter, Randomized, Open-Label Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection Versus Intensive Salvage Therapy in Adult Patients ≤60 Years Old with AML in First Relapse Following an Initial CR >1 Month DurationCancer Center
Calhoun, RoyceA Randomized Phase III Study of Sublobar Resection versus Sublobar Resection Plus Brachytherapy in High Risk Patients with Non-Small Cell Lung Cancer (NSCLC), 3 cm or SmallerCancer Center
Ducore, JonathanRandomized Study of Chimeric Anti-GD-2 in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell RescueCancer Center
Gandara, DavidA Phase II Trial of CCI-779 and Bevacizumab in Patients with Endometrial, Ovarian, Hepatocellular carcinoma, Carcinoid or Islet Cell Cancer (NCI #8233)Cancer Center
Chew, HelenCCRC: A Phase 1 Study of Chronically-Dosed, Single-Agent ABT-888 in Patients with Either BRCA 1/2 Mutated Cancer; Platinum-Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer; or Basal-Like Breast Cancer (NCI #8282)Cancer Center
Lara Jr, PrimoCCRC: A Phase II Selection Design of Pharmacodynamic Separation of Carboplatin/Paclitaxel/OSI-774 (Erlotinib; NSC-718781) or OSI-774 Alone in Advanced Non-Small Lung Cancer (NSCLC) Patients with Performance Status 2 (PS-2) Selected by Serum ProteomicsCancer Center
Smith, LloydPredicting Aromatase Inhibitor Responsiveness In Endometrial CarcinomaMED: OBSTETRICS & GYNECOLOGY
Lara Jr, PrimoCCRC: A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients with Metastatic Castration-Resistant Prostate CancerCancer Center
Agius, MarkCCRC: A Phase II, Double-Blind, Randomized, Multi-Center, Adaptive Dose-Ranging, Placebo-Controlled, Parallel-Group Study Evaluating Safety, Tolerability And Efficacy on MRI Lesion Parameters And Determining The Dose Response Curve Of BAF312 Given Orally Once Daily In Patients With Relapsing-Remitting Multiple Sclerosis [CBAF312A2201, version date 01/12/09] BOLD StudyMED: NEUROLOGY
Welborn, JeannaPhase IIB, Multicenter, Randomized, Open Label Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection Versus Cytarabine and Daunorubicin in Patients with Untreated AML 60-75 Years of AgeCancer Center
Ducore, JonathanTreatment for Very Low, Low and Standard Risk Favorable Histology Wilms TumorCancer Center
Zwerdling, TheodoreTreatment for Very Low, Low and Standard Risk Favorable Histology Wilms TumorCancer Center
Gandara, DavidCCRC: A Phase I and Pharmacokinetic Single Agent Study of Pazopanib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction (NCI #8063)Cancer Center
Satake, NorikoDevelopment of Leukemia Stem Cell Targeted Therapy in Childhood LeukemiaCancer Center
Ducore, JonathanHodgkin Disease (HD) Banking StudyCancer Center
Zwerdling, TheodoreHodgkin Disease (HD) Banking StudyCancer Center
Chen, AllenA Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer who are Treated without SurgeryCancer Center
Agius, MarkCCRC: A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study Comparing The Efficacy And Safety Of 1.25mg FTY720 Administered Orally Once Daily Versus Placebo In Patients With Primary Progressive Multiple Sclerosis [CFTY720D2306, version 8/28/2009]MED: NEUROLOGY
Chen, AllenA Phase II Trial of Sterotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung CancerCancer Center
Tuscano, JosephAn Open-Label, Single-Arm Phase II Study of RAD001 in Patients with Refractory Mantle Cell Lymphoma (EUDRACT 2007-005700-40)Cancer Center
Ducore, JonathanIntensified Methotrexate, Nelarabine (Compound 506U78; IND#52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL)Cancer Center

<< First Page    < Previous Page 1 of 10 Next >    Last Page >>